PLXND1
Basic information
Region (hg38): 3:129555214-129606676
Links
Phenotypes
GenCC
Source: 
- Mobius syndrome (Supportive), mode of inheritance: AD
 - persistent truncus arteriosus (Supportive), mode of inheritance: AR
 - congenital heart defects, multiple types, 9 (Limited), mode of inheritance: AR
 - congenital heart defects, multiple types, 9 (Strong), mode of inheritance: AR
 - Mobius syndrome (Limited), mode of inheritance: AD
 
Clinical Genomic Database
Source: 
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References | 
|---|---|---|---|---|---|
| Congenital heart defects, multiple types, 9 | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular | 24254849; 34791216; 35396997 | 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_specified (255 variants)
 - not_provided (112 variants)
 - PLXND1-related_disorder (42 variants)
 - Congenital_heart_defects,_multiple_types,_9 (11 variants)
 - Kleine-Levin_syndrome (2 variants)
 - Oromandibular-limb_hypogenesis_spectrum (1 variants)
 
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLXND1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015103.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 54 | 62 | ||||
| missense | 260 | 17 | 11 | 292 | ||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 3 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 5 | 0 | 263 | 71 | 19 | 
Highest pathogenic variant AF is 0.0000025611835
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| PLXND1 | protein_coding | protein_coding | ENST00000324093 | 36 | 51644 | 
| pLI Probability LOF Intolerant  | pRec Probability LOF Recessive  | Individuals with no LOFs  | Individuals with Homozygous LOFs  | Individuals with Heterozygous LOFs  | Defined | p | 
|---|---|---|---|---|---|---|
| 1.00 | 4.40e-9 | 125727 | 0 | 21 | 125748 | 0.0000835 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.35 | 821 | 1.14e+3 | 0.721 | 0.0000733 | 12310 | 
| Missense in Polyphen | 254 | 473.98 | 0.53588 | 5136 | ||
| Synonymous | 0.119 | 497 | 500 | 0.993 | 0.0000352 | 3922 | 
| Loss of Function | 7.78 | 7 | 83.9 | 0.0835 | 0.00000415 | 920 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.0000889 | 0.0000889 | 
| Ashkenazi Jewish | 0.000398 | 0.000397 | 
| East Asian | 0.000111 | 0.000109 | 
| Finnish | 0.0000464 | 0.0000462 | 
| European (Non-Finnish) | 0.0000710 | 0.0000703 | 
| Middle Eastern | 0.000111 | 0.000109 | 
| South Asian | 0.0000988 | 0.0000980 | 
| Other | 0.00 | 0.00 | 
dbNSFP
Source: 
- Function
 - FUNCTION: Cell surface receptor for SEMA4A and for class 3 semaphorins, such as SEMA3A, SEMA3C and SEMA3E. Plays an important role in cell-cell signaling, and in regulating the migration of a wide spectrum of cell types. Regulates the migration of thymocytes in the medulla. Regulates endothelial cell migration. Plays an important role in ensuring the specificity of synapse formation. Required for normal development of the heart and vasculature (By similarity). Mediates anti-angiogenic signaling in response to SEMA3E. {ECO:0000250, ECO:0000269|PubMed:20385769}.;
 - Pathway
 - Angiogenesis overview;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;Developmental Biology;Signal Transduction;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH3;Signaling by NOTCH;Other semaphorin interactions;Semaphorin interactions;Plexin-D1 Signaling;Axon guidance 
(Consensus)  
Recessive Scores
- pRec
 - 0.126
 
Intolerance Scores
- loftool
 - 0.160
 - rvis_EVS
 - -1.31
 - rvis_percentile_EVS
 - 4.88
 
Haploinsufficiency Scores
- pHI
 - 0.156
 - hipred
 - Y
 - hipred_score
 - 0.682
 - ghis
 - 0.595
 
Essentials
- essential_gene_CRISPR
 - N
 - essential_gene_CRISPR2
 - N
 - essential_gene_gene_trap
 - N
 - gene_indispensability_pred
 - N
 - gene_indispensability_score
 - 0.167
 
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | High | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
 - Plxnd1
 - Phenotype
 - hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; embryo phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; digestive/alimentary phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype;
 
Zebrafish Information Network
- Gene name
 - plxnd1
 - Affected structure
 - fat cell
 - Phenotype tag
 - abnormal
 - Phenotype quality
 - increased process quality
 
Gene ontology
- Biological process
 - angiogenesis;branching involved in blood vessel morphogenesis;outflow tract morphogenesis;cardiac septum development;negative regulation of cell adhesion;positive regulation of transcription of Notch receptor target;synapse assembly;regulation of cell shape;regulation of cell migration;positive regulation of protein binding;aorta development;regulation of GTPase activity;endothelial cell migration;regulation of angiogenesis;positive regulation of axonogenesis;dichotomous subdivision of terminal units involved in salivary gland branching;coronary vasculature development;semaphorin-plexin signaling pathway;semaphorin-plexin signaling pathway involved in axon guidance
 - Cellular component
 - semaphorin receptor complex;plasma membrane;integral component of plasma membrane;lamellipodium;lamellipodium membrane
 - Molecular function
 - protein binding;semaphorin receptor activity;protein domain specific binding